Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001553350-15-001205
Filing Date
2015-11-12
Accepted
2015-11-12 11:19:33
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDED QUARTERLY REPORT mdst_10q.htm 10-Q/A 344999
2 OFFICER'S CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT mdst_ex31z1.htm EX-31.1 6016
3 OFFICER'S CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT mdst_ex31z2.htm EX-31.2 5989
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 mdst_ex32z1.htm EX-32.1 3246
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 mdst_ex32z2.htm EX-32.2 3285
  Complete submission text file 0001553350-15-001205.txt   1832987

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mdst-20150331.xml EX-101.INS 266577
7 XBRL SCHEMA FILE mdst-20150331.xsd EX-101.SCH 24829
8 XBRL CALCULATION FILE mdst-20150331_cal.xml EX-101.CAL 31489
9 XBRL DEFINITION FILE mdst-20150331_def.xml EX-101.DEF 48449
10 XBRL LABEL FILE mdst-20150331_lab.xml EX-101.LAB 171685
11 XBRL PRESENTATION FILE mdst-20150331_pre.xml EX-101.PRE 119760
Mailing Address 429 KENT STREET UNIT 112 OTTAWA A6 K2P 2B4
Business Address 429 KENT STREET UNIT 112 OTTAWA A6 K2P 2B4 613 241-9969
CTT PHARMACEUTICAL HOLDINGS, INC. (Filer) CIK: 0001035422 (see all company filings)

EIN.: 113763974 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-30651 | Film No.: 151222593
SIC: 1040 Gold and Silver Ores